 Alnylam Pharmaceuticals Inc NASDAQ: ALNY and PeptiDream Inc have announced a license and collaboration agreement to discover and develop peptide-siRNA conjugates to deliver RNAi therapeutics to tissues outside the liver. Under the alliance, Alnylam will pick out a set of receptors, and PeptiDream will tailor-make a peptide for each. 